Skip to main content

Global Eye Health Supplements Market to Surpass 3 billion by 2031 Driven by Rising Prevalence of Various Eye Conditions

SkyQuest projects that the global eye health supplements market will attain a value of USD 3 Billion by 2031, with a CAGR of 5.9% during the forecast period (2024-2031). According to the World Health Organization (WHO), approximately 2.2 billion people across the globe grapple with vision impairment or blindness, highlighting the widespread and profound impact of eye-related health issues.

Westford, USA, Feb. 21, 2024 (GLOBE NEWSWIRE) — According to SkyQuest, the global eye health supplements market is experiencing significant growth, primarily driven by the rising prevalence of various eye conditions, including Age-related Macular Degeneration (AMD), dry eye conditions, cataracts, and inflammation. These eye disorders have become increasingly common due to aging populations and changing lifestyles.

Get sample copy of this report:

https://www.skyquestt.com/sample-request/eye-health-supplements-market

Browse in-depth TOC on the “Eye Health Supplements Market”

  • Pages – 157
  • Tables – 65
  • Figures – 75

The segments focused on supplements for cataracts are experiencing substantial growth, primarily fueled by the increasing recognition of these supplements’ benefits. Research and medical literature have shed light on the potential advantages of certain supplements in mitigating the risk of cataracts in the global eye health supplements market.

Prominent Players in Global Eye Health Supplements Market

  • Bausch Health Companies Inc.
  • Vitabiotics Ltd.
  • Novartis International AG
  • Alcon Inc.
  • The Nature’s Bounty Co.
  • Pfizer Inc.
  • Amway Corporation
  • ZeaVision Holdings, Inc.
  • Valeant Pharmaceuticals International, Inc.
  • Swanson Health Products, Inc.
  • GNC Holdings Inc.
  • Nature’s Way Products, LLC
  • EyePromise
  • The Himalaya Drug Company
  • Nutraceutical Corporation
  • Vitafusion
  • EyeScience Labs, LLC
  • NOW Foods
  • Ocuvite (Abbott Laboratories)
  • Carlson Labs

Browse summary of the report and Complete Table of Contents (ToC):

https://www.skyquestt.com/report/eye-health-supplements-market

Tablets Segment Dominate Market due to its Versatility, Convenience, and Extended Shelf Life

Tablets sector has assumed a commanding position within the global eye health supplements market, representing 40.6% of total sales in 2022. This dominance can be attributed to the versatility and widespread availability of eye health vitamins in tablet format in the global eye health supplements market. These products are offered in various tablet forms, including chewable tablets, sustained-release tablets, and sublingual and buccal tablets.

North America established its prominence in the global eye health supplements market by holding the most significant market revenue share, accounting for 35.6% in 2022. The region is witnessing an escalating prevalence of chronic eye diseases, including Age-related Macular Degeneration (AMD), diabetic retinopathy, glaucoma, and dry eye syndrome, reflecting a growing need for effective eye health solutions.

Softgels Segment to Witness Significant Growth due to their Unique Advantages

The Softgels segment is poised for rapid growth throughout the global eye health supplements market forecast period. Soft gels offer a convenient and effective means of delivering liquid or oil-based nutrients, making them attractive for individuals seeking to support their eye health.

Asia Pacific is poised for rapid growth throughout the forecast period in the global eye health supplements market. Asia Pacific boasts many local market participants who offer innovative and cost-effective eye health supplements, making these products more accessible to a broad consumer base.

A comprehensive analysis of the major players in the global eye health supplements market has been recently conducted in this report. The report encompasses various aspects, including collaborations, mergers, innovative business policies, and strategies, providing valuable insights into key trends and breakthroughs in the market. Furthermore, the report scrutinizes the market share of the top segments and presents a detailed geographic analysis. Lastly, the report highlights the major players in the industry and their endeavours to develop innovative solutions to cater to the growing demand.

Key Developments in Global Eye Health Supplements Market

  • Wellbeing Nutrition recently made a significant entry into the eye health supplement market with the introduction of “Melts Eye Care.” Notably, this product is recognized as the world’s first natural eye vitamin. Wellbeing Nutrition, renowned for its international brand “Melts,” leverages sophisticated nanotechnology to deliver essential vitamins directly into the bloodstream. This innovative approach enhances the accessibility and bioavailability of the vitamins, surpassing the conventional delivery methods of capsules and tablets. “Melts Eye Care” reflects a commitment to advanced and effective eye health supplementation, offering consumers an innovative solution for maintaining and enhancing their vision.
  • In 2022, Entod Pharmaceuticals, a reputable research-based pharmaceutical firm with a rich history spanning nearly four decades in eye diseases, ear-nose-throat (ENT) disorders, and dermatology medicines, introduced the Macusaff pill in the Indian market. This eye care supplement is saffron-based, highlighting its natural and holistic approach to promoting eye health. Entod Pharmaceuticals’ introduction of the Macusaff pill in India underscores the company’s dedication to providing innovative solutions for addressing eye-related concerns and delivering high-quality eye care supplements to consumers in the region.

Speak to Analyst for your custom requirements:

https://www.skyquestt.com/speak-with-analyst/eye-health-supplements-market

Key Questions Answered in the Global Eye Health Supplements Market Report

  • What specific growth drivers are projected to impact the market during the forecast period?
  • List the top companies in the market and explain how they have achieved their positions of influence.

                            

  • In what ways do regional trends and patterns differ within the global market, and how these differences shape the market’s future growth?

Related Reports in SkyQuest’s Library:

Global HIV Drugs Market

Global Vertigo Treatment Market

Global Oral Solid Dosage Pharmaceutical Formulation Market

Global Peripheral Nerve Injuries Market

Global Retinal Disorder Treatment Market

About Us:

SkyQuest Technology is leading growth consulting firm providing market intelligence, commercialization and technology services. It has 450+ happy clients globally.

Address:

1 Apache Way, Westford, Massachusetts 01886

Phone:

USA (+1) 617-230-0741

Email: sales@skyquestt.com

LinkedIn Facebook Twitter

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.